U.S. House Speaker Nancy Pelosi said on Thursday there was
progress in negotiations with the White House, but Senate
Republicans remained skeptical of a possible deal costing
trillions of dollars.
Uncertainly over the timeline of the relief legislature has been
weighing on Wall Street's major indexes, which were set to end a
choppy week slightly lower.
Meanwhile, a record 47 million Americans cast ballots, eclipsing
total early voting from the 2016 election. President Donald
Trump and Democratic rival Joe Biden debated on Thursday for the
last time to persuade the few remaining undecided voters 12 days
before their contest.
At 06:24 a.m. ET, Dow E-minis <1YMcv1> were up 0.31% at 28,352
points, S&P 500 E-minis <EScv1> rose 0.17% to 3,455 points.
Nasdaq 100 E-minis <NQcv1> fell 0.07% to 11,643 points.
Third-quarter earnings season chugged along with 126 S&P firms
having reported so far. About 84% of them have topped quarterly
profit estimates, according to Refinitiv data.
Chipmaker Intel Corp <INTC.O> tumbled nearly 10% in premarket
trading after it reported that margins fell as consumers bought
cheaper laptops and pandemic-stricken businesses and governments
clamped down on data center spending.
Gilead Sciences Inc <GILD.O> jumped 5.8% as its antiviral drug
remdesivir became the first and only drug approved for treating
patients hospitalized with COVID-19 in the United States.
Apple Inc <AAPL.O> edged 0.3% higher as two of its latest iPhone
12 models went on sale in China on Friday.
(Reporting by Medha Singh in Bengaluru; Editing by Arun Koyyur)
[© 2020 Thomson Reuters. All rights
reserved.] Copyright 2020 Reuters. All rights reserved. This material may not be published,
broadcast, rewritten or redistributed.
Thompson Reuters is solely responsible for this content.
|
|